(CIDRAP News) More than 80 additional cases were reported in Germany's enterohemorrhagic Escherichia coli (EHEC) outbreak over the weekend, as European and Russian officials continued to spar over Russia's ban on European vegetables.
(CIDRAP News) A World Health Assembly (WHA)committee that took up a resolution to destroy the remaining stocks of smallpox virus failed to reach an agreement today, despite a working group's attempts to find an acceptable solution.
(CIDRAP News) When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.
(CIDRAP News) Flu activity across the United States continued to show signs of slowing, the Centers for Disease Control and Prevention (CDC) said today.
For the eighth week in a row, the percentage of doctor's visits for flu-like illness dropped, falling to 1.4% from 1.6% the previous week, the CDC reported in its weekly update. All 10 of the CDC's regions stayed below their baseline flu-visit levels.
(CIDRAP News) Signaling that the current flu strains are likely to persist over the next several months, the World Health Organization (WHO) today recommended sticking with the current trio of vaccine strains for the Northern Hemisphere's next influenza season.
The WHO's vaccine strain advisory committee met on Feb 15 and 16 and released its recommendation on the WHO's Web site. The group recommends the following for next season's vaccine:
(CIDRAP News) Global production of the H1N1 influenza vaccine has made clear that the world still has a long way to go to meet pandemic production capacity goals set by the World Health Organization (WHO) 4 years ago, WHO experts said in a report released this week.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.